Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value: $993M (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 42.1%

Value $418M Shares 14,040,000 Est. Cost $21.05 Unrealized +36.5%

IRWD IRONWOOD PHARMACEUTICALS INC 19.0%

Value $189M Shares 16,390,000 Est. Cost $11.52 Unrealized +2.3%

BIIB BIOGEN INC 13.2%

Value $131M Shares 643,000 Est. Cost $278.12 Unrealized -26.5%

INVA INNOVIVA INC 9.8%

Value $97.62M Shares 6,614,000 Est. Cost $13.07 Unrealized +25.3%

GILD GILEAD SCIENCES INC 8.3%

Value $82.94M Shares 1,341,900 Est. Cost $53.90 Unrealized +0.3%

— AMARIN CORP PLC 3.6%

Value $35.76M Shares 23,998,000 Est. Cost $3.97 Unrealized —

— MERSANA THERAPEUTICS INC 2.0%

Value $19.86M Shares 4,299,297 Est. Cost $9.56 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 1.5%

Value $14.71M Shares 1,390,790 Est. Cost $4.84 Unrealized +113.1%

— VOR BIOPHARMA INC 0.3%

Value $3.071M Shares 618,000 Est. Cost $43.10 Unrealized —

— PEAR THERAPEUTICS INC 0.1%

Value $771K Shares 500,356 Est. Cost $6.20 Unrealized —

— REGULUS THERAPEUTICS INC 0.0%

Value $383K Shares 185,183 Est. Cost $2.07 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	14,040,000	$418M	42.1%	$21.05	+36.5%	SHS	G01767105
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$189M	19.0%	$11.52	+2.3%	COM CL A	46333X108
BIIB	BIOGEN INC	643,000	$131M	13.2%	$278.12	-26.5%	COM	09062X103
INVA	INNOVIVA INC	6,614,000	$97.62M	9.8%	$13.07	+25.3%	COM	45781M101
GILD	GILEAD SCIENCES INC	1,341,900	$82.94M	8.3%	$53.90	+0.3%	COM	375558103
—	AMARIN CORP PLC	23,998,000	$35.76M	3.6%	$3.97	—	SPONS ADR NEW	023111206
—	MERSANA THERAPEUTICS INC	4,299,297	$19.86M	2.0%	$9.56	—	COM	59045L106
BCRX	BIOCRYST PHARMACEUTICALS INC	1,390,790	$14.71M	1.5%	$4.84	+113.1%	COM	09058V103
—	VOR BIOPHARMA INC	618,000	$3.071M	0.3%	$43.10	—	COM	929033108
—	PEAR THERAPEUTICS INC	500,356	$771K	0.1%	$6.20	—	CLASS A COM	704723105
—	REGULUS THERAPEUTICS INC	185,183	$383K	0.0%	$2.07	—	COM	75915K309